Publications by authors named "Rene Hopfinger"

Claim this Profile
L
Longitudinal Computed Tomography Indicates No Negative Impact of OnabotulinumtoxinA on Mandibular Bone Density in a 12-Month, Double-Blind, Randomized, Repeat Treatment, Placebo-Controlled Study in Healthy Adults With Masseter Muscle Prominence.
Paul Kostenuik, Sanjay M Mallya, René Hopfinger, Tara Aghaloo, Shawneen Gonzalez

Aesthet Surg J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study.
Deanne Mraz, C William Hanke, Ira Papel, Kenneth Beer, Steven Yoelin, René Hopfinger

Plast Reconstr Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of patient-reported outcome measures for platysma prominence.
Julia K Garcia, Rene M Hopfinger, Catherine Foley, Julie Whyte, Martha Gauthier

Curr Med Res Opin· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial.
Sabrina Fabi, Shannon Humphrey, Brian Biesman, Rosalyn George, Brenda LaTowsky, René Hopfinger

J Am Acad Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platysma Prominence: Review and Expert Analysis of Clinical Presentation, Burden, and Treatment Considerations.
Ada Trindade de Almeida, Koenraad De Boulle, Z Paul Lorenc, Jean Carruthers, Andre Braz, René Hopfinger

Plast Reconstr Surg Glob Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, Placebo-Controlled Study.
Sachin M Shridharani, Patricia Ogilvie, Megan Couvillion, Tatjana Pavicic, Edward Lain, René Hopfinger

Aesthet Surg J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in satisfaction with skin after treatment of facial fine lines with VYC-12 injectable gel: Patient-reported outcomes from a prospective study.
Patricia Ogilvie, Marva Safa, Jonquille Chantrey, Christophe Leys, Maurizio Cavallini, René Hopfinger

J Cosmet Dermatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
Makoto Kawashima, Kiyonori Harii, Yuki Horiuchi, Emily Seidman, Xiaofang Lei, René Hopfinger

Dermatol Surg· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VYC-12 Injectable Gel Is Safe And Effective For Improvement Of Facial Skin Topography: A Prospective Study.
François Niforos, Patricia Ogilvie, Maurizio Cavallini, Christophe Leys, Jonquille Chantrey, René Hopfinger

Clin Cosmet Investig Dermatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects.
Kiyonori Harii, Makoto Kawashima, Nobutaka Furuyama, Xiaofang Lei, René Hopfinger

Aesthetic Plast Surg· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis